OncLive Features Neuroendocrine Tumors in Videos and News Articles

Chemotherapy Options in Neuroendocrine Tumors is the latest video to be released in the OncLive series on Neuroendocrine Tumors. Matthew H. Kulke, MD, Director of the Program in Neuroendocrine and Carcinoid-Tumors at Dana-Farber/Brigham and Women’s Cancer Center in Massachusetts, is the series Moderator.  Insights are provided by panelists Jennifer Eads, MD, Case Western Reserve University; Diane Reidy Lagunes, MD, Memorial Sloan-Kettering Cancer Center; Eric H. Liu, MD, Rocky Mountain Cancer Center; and James C. Yao, MD, The University of Texas MD Anderson Cancer Center. The episodes that have been released to date are listed below:

Episode 1: Clinical and Biological Distinctions in Neuroendocrine Tumors

Episode 2: Disease Factors Influencing Initial Treatment Approaches in NETs

Episode 3: Determining Surgical Candidacy in NETs

Episode 4: Symptom Management in Functional NETs

Episode 5: Goals of Therapy with Somatostatin Analogs in NETs

Episode 6: The Role of Surgery in the Management of NETs

Episode 7: Anti-Angiogenesis and mTOR Inhibition in Carcinoid Tumors

Episode 8: Chemotherapy Options in Neuroendocrine Tumors

OncLive, Kulke, Liu, Eads, Yao, Reidy-Lagunes



Sue O'Dorisio, MD_7Read about the $10.67 million SPORE grant awarded to Dr. Sue O’Dorisio and researchers at the Holden Comprehensive Cancer Center at the University of Iowa for NET research through 4 major projects “exploring the genetics of these tumors, their molecular makeup, and how this information can be used to develop new approaches to diagnosis and treatment.”

University of Iowa NET Research Team_2













Bottom of Form


Print Friendly, PDF & Email